PDGFR blockade is a rational and effective therapy for NPM-ALK–driven lymphomas
Daniela Laimer(Medical University of Vienna), Lukas Kenner(University of Veterinary Medicine Vienna)
Cited by 125
Related Papers
The Implications of PDK1–4 on Tumor Energy Metabolism, Aggressiveness and Therapy Resistance
|Frontiers in Oncology|2020|113
Cell-autonomous GP130 activation suppresses prostate cancer development via STAT3/ARF/p53-driven senescence and confers an immune-active tumor microenvironment
|bioRxiv (Cold Spring Harbor Laboratory)|2024|0
Thyroid hormone receptor beta signaling is a targetable driver of prostate cancer growth
|Molecular Cancer|2025|0